Baclofen PCD Pharma Franchise Company

Cafoli Lifecare offers a Baclofen range of 5 formulations spanning tablets, cream and gel, manufactured in WHO-GMP certified facilities. Distributors serving neurology, orthopaedic and pain-management prescribers can take district-wise monopoly franchise rights for the Baclofen range with full promotional support.

What is Baclofen?

Baclofen is a centrally acting skeletal muscle relaxant and a GABA-B receptor agonist. By stimulating GABA-B receptors in the spinal cord it reduces the transmission of reflexes that cause muscle spasticity, and it is a standard treatment for spasticity due to multiple sclerosis, spinal cord injury and other neurological conditions. Reference: MedlinePlus - Baclofen.

Available Forms

The Cafoli Baclofen portfolio includes oral Tablets for systemic spasticity control and topical Cream and Gel presentations for localised muscle and pain application. Contact us for current pack presentations and trade offers on each form.

Therapeutic Applications

Baclofen is prescribed for spasticity associated with multiple sclerosis, spinal cord injury and cerebral conditions, as well as for painful muscle spasm. Prescribers include neurologists, orthopaedic surgeons, physiotherapists' referring physicians and pain specialists.

Why Baclofen is a High-Potential Molecule for Distributors

Spasticity in neurological patients requires long-term daily dosing, so baclofen tablets generate consistent chronic-therapy refills. Offering topical cream and gel alongside the tablet lets a distributor serve both the neurology segment and the large orthopaedic and pain-management market from a single well-established molecule.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. MedlinePlus: Baclofen
2. PubChem: Baclofen
3. WHO Essential Medicines List - baclofen